Cargando…

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features

SIMPLE SUMMARY: Promoter mutations of the telomerase reverse transcriptase (TERT) gene have been suggested as an oncogenic event in various cancers, including thyroid cancer (TC). GABPB1 is reported to activate TERT gene expression and has been proposed as a cancer therapeutic target. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Xiangling, Mu, Ninni, Yuan, Xiaotian, Wang, Na, Juhlin, C. Christofer, Strååt, Klas, Larsson, Catharina, Neo, Shi Yong, Xu, Dawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946831/ https://www.ncbi.nlm.nih.gov/pubmed/35326537 http://dx.doi.org/10.3390/cancers14061385

Ejemplares similares

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
por: Paulsson, Johan O, et al.
Publicado: (2020)

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma
por: Mu, Ninni, et al.
Publicado: (2018)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
por: Wang, Na, et al.
Publicado: (2016)

Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
por: Xing, Xiangling, et al.
Publicado: (2021)

The GABPB1 gene A/G polymorphism in Polish rowers
por: Maciejewska-Karłowska, A., et al.
Publicado: (2012)

LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells
por: Qi, Wenchuan, et al.
Publicado: (2019)

Acquired hypermethylation of the P16(INK4A) promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
por: Kiss, Nimrod B, et al.
Publicado: (2013)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions
por: Dinets, Andrii, et al.
Publicado: (2015)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Identification of a novel lncRNA GABPB1-IT1 that is downregulated and predicts a poor prognosis in non-small cell lung cancer
por: Xie, Jianjiang, et al.
Publicado: (2019)

Incomplete activation of Alyref and Gabpb1 leads to preimplantation arrest in cloned mouse embryos
por: Ihashi, Shunya, et al.
Publicado: (2023)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
por: Fang, Zhiqing, et al.
Publicado: (2022)

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
por: Juhlin, Carl Christofer
Publicado: (2020)

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
por: Guo, Yanxia, et al.
Publicado: (2019)

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer
por: Nilsson, Joachim N., et al.
Publicado: (2023)

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70
por: Gao, Jiwei, et al.
Publicado: (2021)

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?
por: Stenman, Adam, et al.
Publicado: (2023)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway
por: Chen, Jingyang, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016)

Inflammatory infiltrates in parathyroid tumors
por: Haglund, Felix, et al.
Publicado: (2017)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

Hyperpolarized δ-[1- (13)C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma
por: Minami, Noriaki, et al.
Publicado: (2023)

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report
por: Paulsson, Johan O., et al.
Publicado: (2018)

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

Genetic characterization of large parathyroid adenomas
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_93qegm60f9gvnc2fdgfnbmo1en